SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001005286-24-000084
Filing Date
2024-07-08
Accepted
2024-07-08 17:00:34
Documents
23
Period of Report
2023-05-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A lndc-20240708.htm   iXBRL PRE 14A 1150740
6 lndc-20240708_g1.jpg GRAPHIC 19503
7 lndc-20240708_g2.gif GRAPHIC 576449
8 lndc-20240708_g3.gif GRAPHIC 564193
9 lndc-20240708_g4.gif GRAPHIC 619916
10 lndc-20240708_g5.jpg GRAPHIC 577481
11 lndc-20240708_g6.jpg GRAPHIC 257070
12 lndc-20240708_g7.jpg GRAPHIC 542919
13 lndc-20240708_g8.jpg GRAPHIC 257014
  Complete submission text file 0001005286-24-000084.txt   10628181

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240708.xsd EX-101.SCH 3884
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lndc-20240708_def.xml EX-101.DEF 5517
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240708_lab.xml EX-101.LAB 6667
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240708_pre.xml EX-101.PRE 4190
25 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240708_htm.xml XML 145990
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: PRE 14A | Act: 34 | File No.: 000-27446 | Film No.: 241105640
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)